Swedencare Overview
- Founded
-
2000
- Status
-
Public
- Employees
-
506
- Stock Symbol
-
SECARE
- Investments
-
16
- Share Price
-
$2.51
- (As of Friday Closing)
Swedencare General Information
Description
Swedencare AB is specialized in pet healthcare and produces partly in own factories, markets and sells premium products on the global market. The company has a wide range of brands and products within most therapy areas, which includes Animal Pharmaceuticals, nutravet, NutriScience, PetMD, Stratford, VetWELL as well as ProDen PlaqueOff for oral health to dogs and cats. The company's products are sold in approximately fifty markets.
Contact Information
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Pharmaceuticals
Stock Exchange
STO
Primary Office
- Medeon Science Park
- Per Albin Hanssons väg 41
- 205 12 Malmo
- Sweden
+46 040-859 00
Swedencare Timeline
Swedencare Stock Performance
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $2.51 | $2.39 | $2.25 - $13.53 | $379M | 159M | 469K | $0.13 |
Swedencare Financials Summary
|
In Thousands, USD |
TTM 30-Sep-2022 | FY 2021 31-Dec-2021 | FY 2020 31-Dec-2020 | FY 2019 31-Dec-2019 |
|---|---|---|---|---|
| EV | 773,029 | 2,063,738 | 787,111 | 152,413 |
| Revenue | 164,247 | 89,713 | 26,024 | 13,403 |
| EBITDA | 30,979 | 16,011 | 5,952 | 4,236 |
| Net Income | 15,198 | 6,360 | 3,617 | 3,163 |
| Total Assets | 976,699 | 383,557 | 141,903 | 15,984 |
| Total Debt | 247,024 | 79,729 | 21,785 | 375 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Swedencare Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Swedencare Executive Team (3)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Hakan Lagerberg | Chief Executive Officer | ||
| Jenny Graflind | Chief Financial Officer, Finance | ||
| Jeremy Bates | Vice President of Internal Business Development |
Swedencare Board Members (4)
| Name | Representing | Role | Since |
|---|---|---|---|
| Hakan Lagerberg | Swedencare | Chief Executive Officer | 000 0000 |
| Per Malmstrom | Swedencare | Chairman & Board Member | 000 0000 |
| Thomas Eklund | Self | Board Member | 000 0000 |
Swedencare Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Swedencare Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Swedencare Acquisitions (16)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 000000 000 00 | 01-Nov-2022 | 0000000000 | 000.00 | Other Consumer Non-Durables | 00000 000 |
| 0000000 00000 | 01-Mar-2022 | 0000000000 | 000.00 | Other Consumer Non-Durables | |
| 000000 | 26-Jan-2022 | 0000000000 | 00000 | Food Products | |
| 00000000000 0 | 01-Oct-2021 | 0000000000 | 00.00 | Other Services (B2C Non-Financial) | |
| Vetio Animal Health | 01-Jul-2021 | Merger/Acquisition | 00000 | BPO/Outsource Services |
Swedencare Subsidiaries (11)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| Stratford Animal Health | Other Consumer Non-Durables | Odessa, FL | 2011 |
| 00000000 | Other Consumer Durables | Bolton, United Kingdom | 0000 |
| 000000 000 0000000 | Other Consumer Non-Durables | Loughborough, United Kingdom | 0000 |
| 0000000000 | Distributors/Wholesale | Puget-sur-Argens, France | 0000 |
| 000000 (000000) | Distributors/Wholesale | Pylea Thessaloniki, Greece | 0000 |
Swedencare ESG
Risk Overview
Risk Rating
Updated February, 14, 2023
24.45 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
00.00
Management
Management is related to actions taken to manage ESG issues
00.00
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
00 of 15,231
Rank
00.00
Percentile
Pharmaceuticals
Industry
00 of 899
Rank
00.00
Percentile
Pharmaceuticals
Subindustry
00 of 431
Rank
0.00
Percentile
